Premium
Reply to The Women's Health Initiative; hormone replacement therapy; and Surveillance, Epidemiology, and End Results data and The importance of comprehensive data and statistical testing in the interpretation of breast cancer incidence trends
Author(s) -
Chlebowski Rowan T.,
Aragaki Aaron K.,
Anderson Garnet L.,
Prentice Ross L.
Publication year - 2021
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.33260
Subject(s) - medicine , breast cancer , medroxyprogesterone acetate , hormone therapy , hormone replacement therapy (female to male) , population , progestin , randomized controlled trial , gynecology , cancer , estrogen , placebo , oncology , incidence (geometry) , epidemiology , menopause , alternative medicine , pathology , environmental health , testosterone (patch) , physics , optics